A new publication involving elamipretide was listed on August 31, 2026. The paper, titled "Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress," appears in the journal Physiological Research.
The publication is identified as a comparative evaluation study examining elamipretide, also known as SS-31, alongside MitoQ in a model involving aged female mice under nutritional stress. The event record indicates this is a new addition to the scientific literature rather than a regulatory or trial status update.
No results, conclusions, or comparative outcomes from the study have been provided in this record. This brief reports only the existence and title of the publication as listed in the source database, without characterizing any findings, benefits, or risks associated with elamipretide or MitoQ.
Readers interested in additional background can consult the compound overview for elamipretide for further context.